Molecular mechanism of monoamine oxidase A gene regulation under inflammation and ischemia-like conditions: key roles of the transcription factors GATA2, Sp1 and TBP

被引:37
作者
Gupta, Vinayak [1 ]
Khan, Abrar A. [1 ]
Sasi, Binu K. [1 ]
Mahapatra, Nitish R. [1 ]
机构
[1] Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Cardiovasc Genet Lab, Chennai 600036, Tamil Nadu, India
关键词
GATA2; gene regulation; inflammation; ischemia; monoamine oxidase; Sp1; HYPERACTIVITY DISORDER ADHD; NF-KAPPA-B; A GENE; PROMOTER POLYMORPHISM; MAO-A; BINDING; EXPRESSION; PROTEIN; ALPHA; DNA;
D O I
10.1111/jnc.13099
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidase A (MAOA) plays important roles in the pathogenesis of several neurological and cardiovascular disorders. The mechanism of transcriptional regulation of MAOA under basal and pathological conditions, however, remains incompletely understood. Here, we report systematic identification and characterization of cis elements and transcription factors that govern the expression of MAOA gene. Extensive computational analysis of MAOA promoter, followed by 5-promoter deletion/reporter assays, revealed that the -71/-40bp domain was sufficient for its basal transcription. Gel-shift and chromatin immunoprecipitation assays provided evidence of interactions of the transcription factors GATA-binding protein 2 (GATA2), Sp1 and TATA-binding protein (TBP) with this proximal promoter region. Consistently, over-expression of GATA2, Sp1 and TBP augmented MAOA promoter activity in a coordinated manner. In corroboration, siRNA-mediated down-regulation of GATA2/Sp1/TBP repressed the endogenous MAOA expression as well as transfected MAOA promoter activity. Tumor necrosis factor- and forskolin activated MAOA transcription that was reversed by Sp1 siRNA; in support, tumor necrosis factor-- and forskolin-induced activities were enhanced by ectopic over-expression of Sp1. On the other hand, MAOA transcription was diminished upon exposure of neuroblasts or cardiac myoblasts to ischemia-like conditions because of reduced binding of GATA2/Sp1/TBP with MAOA promoter. In conclusion, this study revealed previously unknown roles of GATA2, Sp1 and TBP in modulating MAOA expression under basal as well as pathophysiological conditions such as inflammation and ischemia, thus providing new insights into the molecular basis of aberrant MAOA expression in neuronal/cardiovascular disease states. Dysregulation of monoamine oxidase A (MAOA) have been implicated in several behavioral and neuronal disease states. Here, we identified three crucial transcription factors (GATA2, Sp1 and TBP) that regulate MAOA gene expression in a coordinated manner. Aberrant MAOA expression under pathophysiological conditions including inflammation and ischemia is mediated by altered binding of GATA2/Sp1/TBP with MAOA proximal promoter. Thus, these findings provide new insights into pathogenesis of several common diseases. GATA2, GATA-binding protein 2; Sp1, specificity protein 1; TBP, TATA-binding protein.
引用
收藏
页码:21 / 38
页数:18
相关论文
共 70 条
[1]   Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury [J].
Bianchi, P ;
Kunduzova, O ;
Masini, E ;
Cambon, C ;
Bani, D ;
Raimondi, L ;
Seguelas, MH ;
Nistri, S ;
Colucci, W ;
Leducq, N ;
Parini, A .
CIRCULATION, 2005, 112 (21) :3297-3305
[2]   H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia:: inhibition by PMA [J].
Bonavita, F ;
Stefanelli, C ;
Giordano, E ;
Columbaro, M ;
Facchini, A ;
Bonafè, F ;
Caldarera, CM ;
Guarnieri, C .
FEBS LETTERS, 2003, 536 (1-3) :85-91
[3]   Specific protein-1 is a universal regulator of UDP-glucose dehydrogenase expression -: Its positive involvement in transforming growth factor-β signaling and inhibition in hypoxia [J].
Bontemps, Y ;
Vuillermoz, B ;
Antonicelli, F ;
Perreau, C ;
Danan, JL ;
Maquart, FX ;
Wegrowski, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) :21566-21575
[4]   Monoamine oxidase inactivation: From pathophysiology to therapeutics [J].
Bortolato, Marco ;
Chen, Kevin ;
Shih, Jean C. .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (13-14) :1527-1533
[5]   BEHAVIORAL OUTCOMES OF MONOAMINE OXIDASE DEFICIENCY: PRECLINICAL AND CLINICAL EVIDENCE [J].
Bortolato, Marco ;
Shih, Jean C. .
MONOAMINE OXIDASES AND THEIR INHIBITORS, 2011, 100 :13-42
[6]   ABNORMAL-BEHAVIOR ASSOCIATED WITH A POINT MUTATION IN THE STRUCTURAL GENE FOR MONOAMINE OXIDASE-A [J].
BRUNNER, HG ;
NELEN, M ;
BREAKEFIELD, XO ;
ROPERS, HH ;
VANOOST, BA .
SCIENCE, 1993, 262 (5133) :578-580
[7]   Disruption of the Serotonergic System after Neonatal Hypoxia-Ischemia in a Rodent Model [J].
Buller, Kathryn M. ;
Wixey, Julie A. ;
Reinebrant, Hanna E. .
NEUROLOGY RESEARCH INTERNATIONAL, 2012, 2012
[8]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[9]   Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway [J].
Chai, Jin ;
He, Yu ;
Cai, Shi-Ying ;
Jiang, Zhongyong ;
Wang, Huaizhi ;
Li, Qiong ;
Chen, Lei ;
Peng, Zhihong ;
He, Xiaochong ;
Wu, Xiaoping ;
Xiao, Tianli ;
Wang, Rongquan ;
Boyer, James L. ;
Chen, Wensheng .
HEPATOLOGY, 2012, 55 (05) :1485-1494
[10]   Lipopolysaccharide improves cardiomyocyte survival and function after serum deprivation [J].
Chao, W ;
Shen, Y ;
Zhu, XS ;
Zhao, HL ;
Novikov, M ;
Schmidt, U ;
Rosenzweig, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) :21997-22005